Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2013

View Archived Issues

Evaluation of an inhalable gene therapy for the treatment of PAH

Researchers at AiCuris synthesize new monobactam derivatives for bacterial infections

Team of researchers at Galecto Biotech patents novel galectin inhibitors

Researchers present phase III results for 99mTc tilmanocept in melanoma patients

Cellceutix to initiate Prurisol clinical trial

Zebrafish model mimics human affective disorders

Phase II trial finds fluorescein an alternative for SLN identification in melanoma

FDA approves ViiV Healthcare's Tivicay for treatment of HIV-1

Identification of a rare genetic deletion with the development of neurodevelopmental disorders

Amarantus reports encouraging preclinical data for MANF in retinitis pigmentosa

MatinasBioPharma receives financing for omega-3 candidate

Cystinosis Research Foundation issues six grants in the U.S. and Canada

U.K.'s MRC supports Cyclacel's seliciclib study in RA

Novel KLB1 inhibitors disclosed by Novartis

Chinese group presents novel agents for cancer and other disorders

Shenogen Pharma Group synthesizes novel agents for cancer

Vifor Pharma and Zeria Pharmaceutical enter licensing agreement for Ferinject

Canadian government provides funding to expand HIV antibody program

Lundbeck divulges novel PDE9 inhibitors for neurodegenerative disorders

Sunovion Pharmaceuticals and Afraxis form drug discovery partnership

ImmuPharma provides update on IPP-204106 cancer program

Methoxyflurane trial meets primary and secondary endpoints

MM-111 receives FDA orphan drug status for gastric and esophageal cancers

Hanmi gains U.S. approval for incrementally modified drug Esomezol

Thomson Reuters, PathGroup and GenoSpace collaborate on personalized oncology medicine service

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...